A shadow market for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Investigational Treatment Acquiring Traction Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.
Active Commerce on Social Networks
Separately, a flourishing market exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before directing customers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Professionals Voice Concerns
Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users injecting products of unknown origin.
Several experts stated the demand for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations.
Some content creators try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and consumer laws, potentially leading to fines, prosecution or prison.
Service Response and Content Elimination
According to the social media company, the platform has taken down problematic content and prohibited associated keywords and search suggestions. The company stated it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies.
Online Trading Operations
Investigations also discovered groups with up to 9,000 members marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of users, populated with images of slimming results, glowing testimonials and step-by-step guides for mixing or administering at home.
Within minutes of joining one community, a vendor posted contact information, where most transactions take place. The seller provided an instruction manual and guaranteed shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about body mass, medical conditions or past usage.
Item Information and Pricing
Inside these groups, messages display dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how long a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Service Oversight and Security Measures
A representative for the messaging service said it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these digital products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.
Her staff has already encountered individuals injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These substances could be contaminated or improperly measured.”
Producer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose patients to possibly significant health risks”.
